Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug;20(35):e2400954.
doi: 10.1002/smll.202400954. Epub 2024 Apr 26.

Enhancing X-Ray Sensitization with Multifunctional Nanoparticles

Affiliations
Review

Enhancing X-Ray Sensitization with Multifunctional Nanoparticles

Jiayi Liu et al. Small. 2024 Aug.

Abstract

In the progression of X-ray-based radiotherapy for the treatment of cancer, the incorporation of nanoparticles (NPs) has a transformative impact. This study investigates the potential of NPs, particularly those comprised of high atomic number elements, as radiosensitizers. This aims to optimize localized radiation doses within tumors, thereby maximizing therapeutic efficacy while preserving surrounding tissues. The multifaceted applications of NPs in radiotherapy encompass collaborative interactions with chemotherapeutic, immunotherapeutic, and targeted pharmaceuticals, along with contributions to photodynamic/photothermal therapy, imaging enhancement, and the integration of artificial intelligence technology. Despite promising preclinical outcomes, the paper acknowledges challenges in the clinical translation of these findings. The conclusion maintains an optimistic stance, emphasizing ongoing trials and technological advancements that bolster personalized treatment approaches. The paper advocates for continuous research and clinical validation, envisioning the integration of NPs as a revolutionary paradigm in cancer therapy, ultimately enhancing patient outcomes.

Keywords: nanoparticle; radiosensitizers; radiotherapy.

PubMed Disclaimer

References

    1. R. A. Chandra, F. K. Keane, F. E. M. Voncken, C. R. Thomas, Lancet 2021, 398, 171.
    1. M. C. Vozenin, J. Bourhis, M. Durante, Nat. Rev. Clin. Oncol. 2022, 19, 791.
    1. Z. Zhang, X. Liu, D. Chen, Signal Transduct. Target. Ther. 2022, 7, 258.
    1. X. Peng, Z. Li, Y. Pei, S. Zheng, J. Liu, J. Wang, R. Li, X. Xu, J. Clin. Oncol. 2024, 23, 837.
    1. L. Z. Braunstein, Lancet 2023, 403, P222,

Publication types

Substances

LinkOut - more resources